Publications by authors named "Isabella Testa"

Claim this Profile
A
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate Cancer.
Fred Saad, Alberto Briganti, Kunhi Parambath Haresh, Egils Vjaters, David Olmos, Isabella Testa

Eur Urol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Inferior Control Arms in Prostate Cancer Trials: The ARANOTE Trial.
Fred Saad, Egils Vjaters, Isabella Testa, Kunhi Parambath Haresh

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial.
Fred Saad, Egils Vjaters, Neal Shore, David Olmos, Nianzeng Xing, Isabella Testa

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Abiraterone Acetate in Castration-resistant Prostate Cancer Patients With Concomitant Cardiovascular Risk Factors.
Giuseppe Procopio, Paolo Grassi, Isabella Testa, Elena Verzoni, Valter Torri

Am J Clin Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile and treatment response of everolimus in different solid tumors: an observational study.
Elena Verzoni, Sara Pusceddu, Roberto Buzzoni, Enrico Garanzini, Angela Damato, Isabella Testa

Future Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data.
Roberto Iacovelli, Matteo Santoni, Elena Verzoni, Paolo Grassi, Isabella Testa

Clin Genitourin Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies: overall results from a large cohort of patients.
Giuseppe Procopio, Isabella Testa, Elena Verzoni, Roberto Iacovelli, Paolo Grassi

Oncology· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to targeted therapy in urachal adenocarcinoma.
Isabella Testa, Elena Verzoni, Paolo Grassi, Maurizio Colecchia, Filomena Panzone

Rare Tumors· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted treatments in advanced renal cell carcinoma: focus on axitinib.
Elena Verzoni, Paolo Grassi, Isabella Testa, Roberto Iacovelli, Pamela Biondani

Pharmgenomics Pers Med· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factor.
Paolo Grassi, Elena Verzoni, Luca Porcu, Isabella Testa, Roberto Iacovelli

Future Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases.
Giuseppe Procopio, Elena Verzoni, Pamela Biondani, Paolo Grassi, Isabella Testa

Tumori· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus in advanced solid tumors: when to start, early or late?
Sara Pusceddu, Anna Tessari, Isabella Testa, Giuseppe Procopio

Tumori· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma: results from a large cohort of patients.
Pamela Biondani, Elena Verzoni, Valter Torri, Luca Porcu, Paolo Grassi, Isabella Testa

Anticancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of collecting duct carcinoma: current status and future perspectives.
Giuseppe Procopio, Isabella Testa, Roberto Iacovelli, Paolo Grassi, Elena Verzoni

Anticancer Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity.
Elena Verzoni, Filippo de Braud, Francesca Fabiani, Paolo Grassi, Isabella Testa

Future Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with sorafenib in the treatment of advanced renal cell carcinoma.
Giuseppe Procopio, Elena Verzoni, Isabella Testa, Nicola Nicolai, Roberto Salvioni

Ther Adv Urol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy.
Luigi Celio, Francesco Agustoni, Isabella Testa, Katia Dotti, Filippo de Braud

Tumori· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lecture: management of chemotherapy-induced febrile neutropenia; guidelines and colony stimulating factors.
Giuseppe Procopio, Monica Niger, Isabella Testa

Neurol Sci· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis